Please provide your email address to receive an email when new articles are posted on . Olezarsen reduced triglycerides and the rate of acute pancreatitis events in patients with severely elevated ...

NEW ORLEANS, LA—DR10624, an investigational drug designed to reduce triglycerides among patients with severely high levels, performed well in a phase II trial, researchers announced today at the ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...

Please provide your email address to receive an email when new articles are posted on . Plozasiran demonstrated durable improvement in triglycerides, APOC3 and other lipid parameters for patients with ...

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice. Yet, in a major ...

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “While pemafibrate reduced triglycerides, VLDL ...

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice. Yet, in a major ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A triple agonist therapy that includes a GLP-1 reduced ...

In a randomized trial of more than 10,000 patients with diabetes, a drug that lowered triglyceride levels did not reduce risk of heart attack, stroke, or cardiovascular death Researchers describe the ...